Meeting Overview - The company will hold its 4th extraordinary general meeting of shareholders in 2025 on September 8, 2025, at 14:30 [2] - The meeting will be conducted both in-person and via online voting [3] - The record date for shareholders to attend the meeting is September 1, 2025 [4] Voting Details - Shareholders can vote through the Shenzhen Stock Exchange trading system from 9:15 to 9:25, 9:30 to 11:30, and 13:00 to 15:00 on the meeting day [2][18] - Online voting will be available from 9:15 to 15:00 on September 8, 2025 [20] - The voting process includes options for approval, disapproval, or abstention on all proposals [16] Attendance Information - All shareholders registered by the record date are entitled to attend the meeting, and they may appoint proxies to represent them [4][5] - The meeting will take place at the Zhaotai International Center, Beijing [8] Agenda and Resolutions - The meeting will review ordinary resolutions that require more than half of the voting rights held by attending shareholders for approval [9] - The agenda items were submitted by the company's ninth board meeting [9] Registration Process - Shareholders can register for the meeting in person, by mail, or by fax from September 2, 2025 [10] - Specific documentation is required for different types of shareholders to register and vote [10] Additional Information - The company will separately count and disclose the voting results of minority investors [9] - Contact information for inquiries is provided, including an email address and phone number [13]

中粮生物科技股份有限公司 关于召开 2025 年第 4 次临时股东大会的提示性公告 证券代码：000930 证券简称：中粮科技 公告编号：2025-067 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 中粮生物科技股份有限公司（以下简称公司）已于 2025 年 8 月 22 日在《中 国证券报》《证券时报》《证券日报》《上海证券报》和巨潮资讯网 （www.cninfo.com.cn）上刊登了《中粮科技：关于召开 2025 年第 4 次临时股东 大会的通知》（公告编号：2025-064）。为保护投资者的合法权益，方便公司股 东行使股东大会表决权，本次股东大会将通过深圳证券交易所系统及互联网投票 系统向社会公众股股东提供网络形式的投票平台。现发布公司关于召开 2025 年 第 4 次临时股东大会的提示性公告如下： 一、召开会议的基本情况 门规章、规范性文件和《公司章程》等相关规定和要求。 现场会议召开时间：2025 年 9 月 8 日（星期一）14:30 网络投票时间：通过深交所交易系统进行网络投票时间为 2025 年 9 月 8 日 日 9:15-15:00。 公 ...

证券代码：000930 证券简称：中粮科技 公告编号：2025-067 中粮生物科技股份有限公司 关于召开 2025 年第 4 次临时股东大会的提示性公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 中粮生物科技股份有限公司（以下简称公司）已于 2025 年 8 月 22 日在《中 国证 券报》《 证券时 报》《 证券日报 》《上 海证券报 》和巨 潮资讯网 （www.cninfo.com.cn）上刊登了《中粮科技：关于召开 2025 年第 4 次临时股东 大会的通知》（公告编号：2025-064）。为保护投资者的合法权益，方便公司股 东行使股东大会表决权，本次股东大会将通过深圳证券交易所系统及互联网投票 系统向社会公众股股东提供网络形式的投票平台。现发布公司关于召开 2025 年 第 4 次临时股东大会的提示性公告如下： 一、召开会议的基本情况 1.股东大会届次：2025 年第 4 次临时股东大会 2.股东大会的召集人：公司董事会 3.会议召集的合法、合规性：本次会议的召开符合有关法律、行政法规、部 门规章、规范性文件和《公司章程》等相关规定和要求。 7.出 ...

人民财讯9月2日电，企查查APP显示，近日，安徽中粮生物技术有限公司成立，法定代表人为罗虎，注 册资本为2.5亿元，经营范围包含：生物基材料技术研发；生物基材料聚合技术研发；生物基材料制 造；生态环境材料制造等。企查查股权穿透显示，该公司由中粮生物材料(榆树)有限公司全资持股，后 者由中粮科技（000930）、航天投资控股有限公司等共同持股。 ...

Group 1 - Company announced the resignation of its securities affairs representative, Sun Shuyuan, due to personal reasons [1] - After her resignation, Sun Shuyuan will no longer hold any position within the company [1]

证券代码：000930 证券简称：中粮科技 公告编号：2025-066 中粮生物科技股份有限公司 关于证券事务代表辞职的公告 孙淑媛女士在担任公司证券事务代表期间恪尽职守、勤勉尽责，公司及公司 董事会对孙淑媛女士在任职期间为公司所做出的贡献表示衷心感谢！ 孙淑媛女士已完成所负责相关工作的交接，其辞职不会对公司相关工作及生 产经营产生影响。公司董事会将按相关规定，尽快聘任符合任职资格的人员担任 证券事务代表。 特此公告。 中粮生物科技股份有限公司 董事会 2025 年 8 月 29 日 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 中粮生物科技股份有限公司（以下简称 公司）董事会于近日收到证券事务 代表孙淑媛女士提交的书面辞职报告。孙淑媛女士因个人原因，申请辞去公司证 券事务代表职务，辞职后不再担任公司任何职务，其辞职申请自送达公司董事会 之日起生效。截至本公告披露日，孙淑媛女士未持有公司股份。 ...

Group 1 - The grain concept sector experienced a decline of 1.01%, ranking among the top declines in the concept sectors, with notable declines in stocks such as Yalian Development, QuanYin High-Tech, and Wanxiang DeNong [1] - Among the grain concept stocks, 39 experienced net outflows from main funds, with a total outflow of 504 million yuan, led by Beidahuang with a net outflow of 57.84 million yuan [1] - The top gainers in the grain concept sector included COFCO Technology, Lianhua Holdings, and Ruimaotong, with increases of 0.81%, 0.78%, and 0.66% respectively [1] Group 2 - The top concept sectors for gains included Copper Cable High-Speed Connection with a rise of 5.61%, and Co-Packaged Optics (CPO) with a rise of 5.13%, while the Transgenic sector fell by 1.81% [1] - The grain concept sector saw significant net outflows, with six stocks experiencing outflows exceeding 30 million yuan, including ChuanNing Biological and Lianhua Holdings [1][2] - The main funds saw inflows in stocks such as Ruimaotong, Guangyu Group, and JiaHua Shares, with inflows of 5.29 million yuan, 3.44 million yuan, and 2.75 million yuan respectively [2]

Core Viewpoint - COFCO Biotech reported a significant increase in net profit for the first half of 2025, achieving a net profit attributable to shareholders of 107 million, a year-on-year increase of 74.4% [1]. Financial Performance - The company achieved a net profit of 107 million, up 74.4% year-on-year, and a non-recurring net profit of 31.9 million, up 71.5% [1]. - Despite stable production rates and overall sales, sales revenue decreased due to falling product prices, although gross margins for key products improved [1]. - The overall gross margin increased by 1.3 percentage points year-on-year, approaching 8.5%, with specific product contributions noted [2]. Business Strategies - The company implemented several cost-reduction measures, including enhancing procurement and sales integration, optimizing inventory management, and adopting a "slow procurement, fast sales" strategy [1]. - The company is focusing on new product sales, such as flavored syrups and modified starches, to improve overall gross margins [1]. - The enzyme-based production of allulose has received approval from the health authority, providing a first-mover advantage in the domestic market [1]. Business Segment Insights - Fuel ethanol business remains stable with a market demand of 3-3.5 million tons, and the company maintains a high market share [2]. - The starch sugar business is expanding, with a 150,000-ton expansion project nearing completion and expected to start production by the end of September [2]. - The allulose product is positioned as a key growth area, with significant investment in enzyme research and development, and is expected to see increased demand in the beverage and baking sectors [2]. Future Outlook - The company plans to optimize raw material structure and expand market demand to drive growth in the fuel ethanol segment [2]. - The company is also preparing for the construction of a new starch production facility with an investment of nearly 1 billion, expected to start construction in Q4 of this year [2]. - The allulose product is anticipated to gain traction in the market, with potential for unexpected demand growth if it becomes a popular product [2].

Financial Performance - In the first half of 2025, COFCO Biotechnology achieved a net profit attributable to shareholders of 107 million, a year-on-year increase of 74.4% [2] - The non-recurring net profit was 31.9 million, up 71.5% year-on-year [2] - The overall gross margin improved, with a comprehensive gross margin nearing 8.5%, an increase of 1.3 percentage points year-on-year [3] Sales and Production - Despite stable production rates and overall sales, sales revenue decreased due to a drop in product prices [2] - The company maintained a high production and sales rate, with total sales volume remaining consistent with the previous year [3] - The sales revenue of fuel ethanol, starch sugar, and monosodium glutamate products saw a decline due to lower raw material prices and insufficient downstream demand [4] Cost Control Measures - The company implemented several cost-reduction strategies, including: - Strengthening the integration of procurement and sales to manage inventory effectively [2] - Utilizing hedging strategies to control risks related to raw material and product pricing [2] - Continuous improvement of production processes to lower comprehensive production costs [2] - Increasing sales of niche products such as flavored syrups and modified starches to enhance overall gross margin [2] Project Developments - Key projects are progressing as planned, including: - The relocation of the polylactic acid project and the expansion of the Chengdu company's fructose production capacity [3] - The construction of a new starch sugar project in Taicang with an annual capacity of 550,000 tons, expected to start construction in Q4 2025 [4] - The enzyme-based production of allulose has received approval from the health authority, establishing a market advantage for the company [3] Business Segment Insights - The fuel ethanol business remains stable, with market demand between 3 to 3.5 million tons [4] - The starch sugar business is a key focus area, with significant investments in capacity expansion and expected stable production post-launch [4] - The allulose product is positioned as a critical growth area, with optimistic market potential anticipated over the next 2-3 years [5]

证券代码：000930 证券简称：中粮科技 公告编号：2025-065 公司于近日收到中国银行间市场交易商协会（以下简称交易商协会）的《接 受注册通知书》（中市协注〔2025〕SCP220 号），交易商协会决定接受公司超 短期融资券注册。现就有关事项公告如下： 一、公司超短期融资券注册金额为 30 亿元，注册额度自通知书落款之日起 2 年内有效，由招商银行股份有限公司主承销。 二、公司在注册有效期内可分期发行超短期融资券，发行完成后，应通过交 易商协会认可的途径披露发行结果。 公司将根据上述《接受注册通知书》要求，按照超短期融资券注册发行的有 关规定，择机实施本次超短期融资券发行事宜，并按照相关规定及时履行信息披 露义务。 中粮生物科技股份有限公司 关于收到中国银行间市场交易商协会《接受注册通知书》的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 中粮生物科技股份有限公司（以下简称公司）分别于 2025 年 3 月 7 日召开 九届董事会 2025 年第 3 次临时会议、2025 年 3 月 25 日召开 2025 年第 2 次临时 股东大会，审议通过了《关 ...